These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Sodium ferric gluconate complex maintenance therapy in children on hemodialysis. Warady BA; Zobrist RH; Finan E; Pediatr Nephrol; 2006 Apr; 21(4):553-60. PubMed ID: 16520948 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics, safety and tolerability of intravenous ferric carboxymaltose: a dose-escalation study in volunteers with mild iron-deficiency anaemia. Geisser P; Banké-Bochita J Arzneimittelforschung; 2010; 60(6a):362-72. PubMed ID: 20648928 [TBL] [Abstract][Full Text] [Related]
10. Safety of iron sucrose in hemodialysis patients intolerant to other parenteral iron products. Charytan C; Schwenk MH; Al-Saloum MM; Spinowitz BS Nephron Clin Pract; 2004; 96(2):c63-6. PubMed ID: 14988600 [TBL] [Abstract][Full Text] [Related]
11. Drug insight: Safety of intravenous iron supplementation with sodium ferric gluconate complex. Michael B; Fishbane S; Coyne DW; Agarwal R; Warnock DG Nat Clin Pract Nephrol; 2006 Feb; 2(2):92-100. PubMed ID: 16932400 [TBL] [Abstract][Full Text] [Related]
12. Single-dose pharmacokinetics of sodium ferric gluconate complex in iron-deficient subjects. Seligman PA; Dahl NV; Strobos J; Kimko HC; Schleicher RB; Jones M; Ducharme MP Pharmacotherapy; 2004 May; 24(5):574-83. PubMed ID: 15162891 [TBL] [Abstract][Full Text] [Related]
13. Intravenous iron replacement with sodium ferric gluconate complex in sucrose for iron deficiency anemia in adults. Kane RC Curr Ther Res Clin Exp; 2003 Apr; 64(4):263-8. PubMed ID: 24944373 [TBL] [Abstract][Full Text] [Related]
14. Intravenous ferric carboxymaltose versus standard medical care in the treatment of iron deficiency anemia in patients with chronic kidney disease: a randomized, active-controlled, multi-center study. Charytan C; Bernardo MV; Koch TA; Butcher A; Morris D; Bregman DB Nephrol Dial Transplant; 2013 Apr; 28(4):953-64. PubMed ID: 23222534 [TBL] [Abstract][Full Text] [Related]
15. TREATMENT OF ANEMIA AND IMPROVEMENT OF QUALITY OF LIFE AMONG PATIENTS WITH CROHN'S DISEASE: experience using ferric carboxymaltose. Sobrado CW; Cançado RD; Sobrado LF; Frugis MO; Sobrado MF Arq Gastroenterol; 2015 Dec; 52(4):255-9. PubMed ID: 26840464 [TBL] [Abstract][Full Text] [Related]
16. Safety and Effectiveness of an Accelerated Intravenous Iron Administration Protocol in Hospitalized Patients With Heart Failure. Eche IM; Owen KL; Eche IJ; Patel P; Sabe M J Cardiovasc Pharmacol Ther; 2021 Jul; 26(4):365-370. PubMed ID: 33563034 [TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of iron sucrose for iron deficiency in patients with dialysis-associated anemia: North American clinical trial. Charytan C; Levin N; Al-Saloum M; Hafeez T; Gagnon S; Van Wyck DB Am J Kidney Dis; 2001 Feb; 37(2):300-7. PubMed ID: 11157370 [TBL] [Abstract][Full Text] [Related]
18. Safety profile of a high dose ferric gluconate in patients with severe chronic renal insufficiency. Jain AK; Bastani B J Nephrol; 2002; 15(6):681-3. PubMed ID: 12495284 [TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of iron sucrose in patients sensitive to iron dextran: North American clinical trial. Van Wyck DB; Cavallo G; Spinowitz BS; Adhikarla R; Gagnon S; Charytan C; Levin N Am J Kidney Dis; 2000 Jul; 36(1):88-97. PubMed ID: 10873877 [TBL] [Abstract][Full Text] [Related]
20. Weekly administration of high-dose sodium ferric gluconate is safe and effective in peritoneal dialysis patients. Javier AM Nephrol Nurs J; 2002 Apr; 29(2):183-6. PubMed ID: 11997953 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]